跳至主要内容
临床试验/NCT02862834
NCT02862834已完成不适用

Towards an Improvement in Diagnosis and Genetic Counselling in Syndromic Poikiloderma

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2013年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
1
主要终点
Identification of novel genes involved in syndromic poikiloderma

研究概览

简要总结

In the context of this study, the investigators wish to take advantage of high-throughput genetic techniques (microarray and high-throughput exome sequencing) to identify new genes implicated in syndromic poikiloderma so as to improve the diagnostic decision tree in these syndromes, opportunities for genetic counselling for patients and their families and the follow-up of patients, notably with regard to the risk of tumours.

This study will make it possible to identify new genes implicated in syndromic poikiloderma and improve the diagnostic strategy proposed to patients with these syndromes, and to propose to patients a confirmed diagnosis, appropriate follow-up, notably with regard to the risk of tumours, genetic counselling to families and eventually an antenatal diagnosis to couples who would like to have one for future pregnancies.

The identification of new genetic causes of syndromic poikiloderma will also make it possible to complete the current classification of these syndromes

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients with syndromic poikiloderma, defined by the association of poikiloderma with other extradermatological clinical signs,
  • normal array-CGH, screening for chromosomal rearrangements,
  • absence of mutations in the genes RECQL4, KIND1 or C16orf57,
  • sporadic or familial involvement.

排除标准

  • 未提供

研究组 & 干预措施

patients with poikiloderma

干预措施: High-throughput exome sequencing (Genetic)

结局指标

主要结局

Identification of novel genes involved in syndromic poikiloderma

时间窗: day 1

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验